13 Results for "

Bacterial killing

" in MedChemExpress (MCE) Product Catalog:
Products (13)

13 Results for "Bacterial killing" in MCE Product Catalog:

34
34 Publications Verification
Cat. No.: HY-B0013
CAS No.: 294662-18-3
Synonyms: (-)-Ofloxacin lactate
Research Areas:  

Infection

Lavofloxacin lactate ((-)-ofloxacin lactate) is a class of broad-spectrum antimicrobials that can kill or inhibit a variety of bacteria. Lavofloxacin lactate binds to DNA rotase and topoisomerase IV, resulting in blocked DNA replication and repair, thus inhibiting bacterial growth. Lavofloxacin lactate can be used to study resistance mechanisms in bacteria, including studying resistance genes and mutations .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-D1056B3
Synonyms: LPS, from Bacterial (Klebsiella pneumoniae)
Lipopolysaccharides, from Klebsiella pneumoniae (LPS, from bacterial (Klebsiella pneumoniae)) are lipopolysaccharide endotoxins and TLR4 activators derived from Klebsiella pneumoniae, and are classified as S-type LPS. Lipopolysaccharides, from Klebsiella pneumoniae exhibit a typical three-part structure: O-antigen, core oligosaccharide, and lipid A. Lipopolysaccharides, from Klebsiella pneumoniae may participate in bacterial immune evasion by inhibiting complement-mediated killing and suppressing the host's secretion of antimicrobial peptides, thereby allowing the bacteria to escape immune defenses. Lipopolysaccharides, from Klebsiella pneumoniae possess high viscosity and resistance to serum-mediated killing, which may lead to sepsis. Lipopolysaccharides, from Klebsiella pneumoniae can be used to construct Acute Lung Injury Model .
It is recommended to prepare a solution with concentration ≥2 mg/mL. Vortex thoroughly for more than 10 minutes. Due to the adsorption characteristics of LPS, silanized container or low adsorption centrifuge tubes should be used for aliquoting and storage, and mix thoroughly before use.
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-Y0532
CAS No.: 128-09-6
Synonyms: Succinchlorimide
N-Chlorosuccinimide (Succinchlorimide) is an oxidizing, hydrolyzable biochemical reagent with bactericidal and amoebicidal activities. N-Chlorosuccinimide can either form N-chloramines via concerted transfer of Cl + or hydrolyze in aqueous solution to produce hypochlorous acid/hypochlorite. N-Chlorosuccinimide is effective in killing Shigella dysenteriae, Escherichia typhi and cysts of Entamoeba histolytica. N-Chlorosuccinimide can be formulated into fast-dispersing, fully soluble water purification tablets. N-Chlorosuccinimide is used in studies related to bacterial infections and parasitic infections .
loading...
    loading...
Cat. No.: HY-121310
CAS No.: 574-93-6
Purity:  ≥98.0%
Phthalocyanine is a type of pigment and Photosensitizer. Upon irradiation, Phthalocyanine generates ROS or converts light energy into heat, inducing oxidative damage, cytotoxicity, and photodynamic killing of bacterial biofilms. Phthalocyanine produces chemiluminescence when oxidized. It can be used in studies related to cancer, bacterial infections, and photodynamic approaches .
loading...
    loading...
Cat. No.: HY-P10696
CAS No.: 2154327-48-5
Target:  

Bacterial

Research Areas:  

Infection

C16G2 is a specific targeted antimicrobial peptide (STAMP) that targets the cariogenic oral pathogen Streptococcus mutans. C16G2 specifically recognizes and disrupts the bacterial cell membrane, causing small molecule leakage and loss of membrane potential, leading to bacterial killing. C16G2 exhibits higher selectivity and efficacy against Streptococcus mutans, unlike broad-spectrum antimicrobial peptides .
loading...
    loading...
Cat. No.: HY-136512
CAS No.: 80152-07-4
Purity:  98.65%
Streptazolin is an antibiotic. Streptazolin increases bacterial killing and elaboration of immunostimulatory cytokines by macrophages in vitro. Streptazolin stimulates the macrophage NF-κB pathway via PI3K signaling .
loading...
    loading...
Cat. No.: HY-P10696A
Target:  

Bacterial

Research Areas:  

Infection

C16G2 TFA is a specific targeted antimicrobial peptide (STAMP) that targets the cariogenic oral pathogen Streptococcus mutans. C16G2 TFA specifically recognizes and disrupts the bacterial cell membrane, causing small molecule leakage and loss of membrane potential, leading to bacterial killing. C16G2 TFA exhibits higher selectivity and efficacy against Streptococcus mutans, unlike broad-spectrum antimicrobial peptides .
loading...
    loading...
Cat. No.: HY-Y0532R
CAS No.: 128-09-6
Synonyms: Succinchlorimide (Standard)
N-Chlorosuccinimide (Standard) (Succinchlorimide (Standard)) is the analytical standard of N-Chlorosuccinimide (HY-Y0532). This product is intended for research and analytical applications. N-Chlorosuccinimide (Succinchlorimide) is an oxidizing, hydrolyzable biochemical reagent with bactericidal and amoebicidal activities. N-Chlorosuccinimide can either form N-chloramines via concerted transfer of Cl + or hydrolyze in aqueous solution to produce hypochlorous acid/hypochlorite. N-Chlorosuccinimide is effective in killing Shigella dysenteriae, Escherichia typhi and cysts of Entamoeba histolytica. N-Chlorosuccinimide can be formulated into fast-dispersing, fully soluble water purification tablets. N-Chlorosuccinimide is used in studies related to bacterial infections and parasitic infections .
loading...
    loading...
Cat. No.: HY-164369
CAS No.: 22812-29-9
Target:  

Bacterial

Research Areas:  

Infection

Antibiofilm agent-10 is an antibiofilm agent, which reduces bacterial levels and improves wound healing in recalcitrant pressure ulcers (PUs) in combination with negative pressure wound therapy (NPWT). Antibiofilm agent-10 enhances pathogen killing efficacy of antimicrobials .
loading...
    loading...
Cat. No.: HY-115693
CAS No.: 2292123-03-4
Target:  

Bacterial

Research Areas:  

Infection

CAP 3 is a cholic acid-peptide conjugate (CAP) antimicrobial agent. CAP 3 effectively inhibits Gram-negative bacteria, with MIC99 (minimum inhibitory concentration for 99% bacterial killing) values of 8 μM, 16 μM, and 16 μM against E. coli, Klebsiella pneumoniae and Acinetobacter baumannii, respectively. CAP 3 exerts its antibacterial effects by disrupting the structural integrity of the bacterial lipopolysaccharide (LPS) outer membrane. CAP 3 rapidly kills bacteria, inhibits biofilm formation, and effectively combats drug-resistant strains and persistent bacterial infections .
loading...
    loading...
Cat. No.: HY-178738
CAS No.: 1371629-36-5
GC-072 is an orally active, 4-oxoquinolizine antibiotic that selectively inhibits bacterial DNA gyrase and Topo IV enzymes. GC-072 does not inhibit human topoisomerases I and II. GC-072 demonstrates strong antimicrobial activity against various bacterial strains, including Gram-positive, Gram-negative, and resistant bacteria. GC-072 also exhibits bactericidal activity against Burkholderia pseudomallei both extracellularly and intracellularly, leading to dose-dependent survival in mice exposed to lethal inhalational models of B. pseudomallei infection. GC-072 can be used for the research of melioidosis .
loading...
    loading...
Cat. No.: HY-168626A
CAS No.: 2841472-37-3
Target:  

Bacterial

Research Areas:  

Infection

Antibacterial agent 252 hydrochloride is an amino acid derivative with antibacterial activity. Antibacterial agent 252 hydrochloride enhances the killing of colistin sulfate (HY-A0089) against a variety of gram-negative bacteria by targeting the bacterial membrane .
loading...
    loading...
Cat. No.: HY-L049
1,977 compounds

Antibacterial agents are a group of materials that fight against pathogenic bacteria. Thus, by killing or reducing the metabolic activity of bacteria, their pathogenic effect in the biological environments will be minimized. The most widely used antibacterial agents exert their effects on bacterial cell wall synthesis, protein synthesis, DNA replication and metabolic pathways. However, resistance to antimicrobial agents has become a major source of morbidity and mortality worldwide. The main mechanisms of resistance are limiting uptake of a drug, modification of a drug target, inactivation of a drug, and active efflux of a drug. Therefore, it is an urgent need to develop new drugs targeted at resistant organisms.

MCE offers a unique collection of 1,977 compounds with validated antibacterial activities. MCE antibacterial compound library is an effective tool for drug repurposing screening, combination screening and biological investigation.

  • 1